Gabrielle Lopez

835 total citations
7 papers, 55 citations indexed

About

Gabrielle Lopez is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Infectious Diseases. According to data from OpenAlex, Gabrielle Lopez has authored 7 papers receiving a total of 55 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 3 papers in Pulmonary and Respiratory Medicine and 1 paper in Infectious Diseases. Recurrent topics in Gabrielle Lopez's work include Cancer Immunotherapy and Biomarkers (6 papers), Lung Cancer Research Studies (3 papers) and Lung Cancer Treatments and Mutations (3 papers). Gabrielle Lopez is often cited by papers focused on Cancer Immunotherapy and Biomarkers (6 papers), Lung Cancer Research Studies (3 papers) and Lung Cancer Treatments and Mutations (3 papers). Gabrielle Lopez collaborates with scholars based in United States. Gabrielle Lopez's co-authors include Carolyn J. Presley, Dwight H. Owen, Andrew Johns, Madison Grogan, Kari Kendra, Mingjia Li, Gregory A. Otterson, Gabriel Tinoco, Lai Wei and Marium Husain and has published in prestigious journals such as Journal of Clinical Oncology, Journal of the American Society of Nephrology and Cancer Immunology Immunotherapy.

In The Last Decade

Gabrielle Lopez

6 papers receiving 55 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gabrielle Lopez United States 4 47 22 13 9 7 7 55
T. Comont France 2 35 0.7× 9 0.4× 13 1.0× 7 0.8× 10 1.4× 2 47
Kunal Dalal United States 3 37 0.8× 46 2.1× 4 0.3× 10 1.1× 4 0.6× 13 61
Pietro Sozzi Italy 3 37 0.8× 17 0.8× 14 1.1× 9 1.0× 4 0.6× 4 52
Ankit Rao United Kingdom 3 32 0.7× 8 0.4× 6 0.5× 6 0.7× 9 1.3× 16 49
Rita Gasbarra Italy 5 41 0.9× 21 1.0× 6 0.5× 13 1.4× 2 0.3× 7 47
Imelda Maria Loho Indonesia 5 16 0.3× 6 0.3× 24 1.8× 13 1.4× 22 3.1× 11 62
Giovanna Luchena Italy 6 34 0.7× 14 0.6× 2 0.2× 5 0.6× 3 0.4× 10 56
Till Wallrabenstein Switzerland 3 29 0.6× 14 0.6× 5 0.4× 7 0.8× 2 0.3× 4 36
Yusuke Noguchi Japan 6 23 0.5× 8 0.4× 4 0.3× 3 0.3× 3 0.4× 12 51
Jean Bustamante Alvarez United States 3 41 0.9× 10 0.5× 11 0.8× 5 0.6× 2 0.3× 5 58

Countries citing papers authored by Gabrielle Lopez

Since Specialization
Citations

This map shows the geographic impact of Gabrielle Lopez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gabrielle Lopez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gabrielle Lopez more than expected).

Fields of papers citing papers by Gabrielle Lopez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gabrielle Lopez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gabrielle Lopez. The network helps show where Gabrielle Lopez may publish in the future.

Co-authorship network of co-authors of Gabrielle Lopez

This figure shows the co-authorship network connecting the top 25 collaborators of Gabrielle Lopez. A scholar is included among the top collaborators of Gabrielle Lopez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gabrielle Lopez. Gabrielle Lopez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Wong, Alex H.C., Songzhu Zhao, Mingjia Li, et al.. (2023). Association between pre-treatment chest imaging and pulmonary function abnormalities and immune checkpoint inhibitor pneumonitis. Cancer Immunology Immunotherapy. 72(6). 1727–1735. 8 indexed citations
2.
Tinoco, Gabriel, Songzhu Zhao, Lai Wei, et al.. (2022). Immune checkpoint inhibitor-induced hepatitis injury: risk factors, outcomes, and impact on survival. Journal of Cancer Research and Clinical Oncology. 149(5). 2235–2242. 25 indexed citations
3.
Wong, Alex, Songzhu Zhao, Jing Wang, et al.. (2022). HSR22-165: Pulmonary Function Tests (PFTs) and Immune Checkpoint Inhibitor Pneumonitis. Journal of the National Comprehensive Cancer Network. 20(3.5). HSR22–165.
4.
Zhang, Shijun, Chien‐Wei Chiang, Gregory A. Otterson, et al.. (2021). Comparative assessment of manual chart review and ICD claims data in evaluating immunotherapy-related adverse events. Cancer Immunology Immunotherapy. 70(10). 2761–2769. 10 indexed citations
5.
Husain, Marium, Menglin Xu, Sandipkumar Patel, et al.. (2021). Proton pump inhibitor use (PPI) in patients treated with immune checkpoint inhibitors (ICI) for advanced cancer: Survival and prior therapy.. Journal of Clinical Oncology. 39(15_suppl). 2633–2633. 9 indexed citations
6.
Zhao, Songzhu, Sandip H. Patel, Andrew Johns, et al.. (2021). Immune checkpoint inhibitor induced hepatitis: Risk factors, outcomes, and impact on survival.. Journal of Clinical Oncology. 39(15_suppl). e14525–e14525. 2 indexed citations
7.
Prosek, Jason, Dwight H. Owen, Marium Husain, et al.. (2020). Statin Use, Renal Cell Carcinoma, and Combination Immunotherapy Increase Risk of Checkpoint Inhibitor-Induced Nephritis: A Single-Center Database Study. Journal of the American Society of Nephrology. 31(10S). 663–663. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026